Name: Juvmo (tavapadon) in Parkinson's disease: Dosage forms and strengths
Published: 2026-09-27T21:44:59-04:00

Product information and disease description Product description Product information

Dosage forms and strengths

6 evidence topics · 3 sources

Tablet strengths and descriptions

“Tablets: 0.25 mg, 1 mg, 5 mg, 10 mg, and 15 mg (3)” (opens the prescribing information at this quote)
“Each film-coated tablet contains 0.25 mg, 1 mg, 5 mg, 10 mg, or 15 mg tavapadon.” (opens the prescribing information at this quote)

Tablet descriptions by strength

Strength	Quoted description
0.25 mg	“Round, orange, film-coated”
1 mg	“Rectangle, orange, film-coated”
5 mg	“Diamond, purple, film-coated”
10 mg	“Oval, purple, film-coated”
15 mg	“Rectangle, purple, film-coated”

Inactive ingredients

“0.25 mg and 1 mg tablets: Lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, red iron oxide, sodium starch glycolate, talc, titanium dioxide, and yellow iron oxide.” (opens the prescribing information at this quote)
“5 mg, 10 mg, and 15 mg tablets: Carmine, FD&C Blue No. 2, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium starch glycolate, talc, and titanium dioxide.” (opens the prescribing information at this quote)

Storage and handling

“Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature].” (opens the prescribing information at this quote)

Bioequivalence of the 15 mg tablet and three 5 mg tablets

“The primary purpose of the study is to evaluate the bioequivalence (BE) of tavapadon 15 milligram (mg) tablet to 3x5 mg tablets in participants with Parkinson's disease.” (opens the source at this quote in a new tab)

Relative bioavailability of clinical and commercial tablets

“A Phase 1, Two Part, Randomized, Single and Multiple Dose Crossover Study to Assess the Relative Bioavailability Between Tavapadon Clinical and Commercial Tablets” (opens the source at this quote in a new tab)